CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Grant or award EVP and Chief Medical Officer acquired 4,658 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Returned to the company SVP, Chief Accounting Officer returned 181 shares (to the company)
- 4 Open-market sale EVP and Chief Medical Officer sold 3,881 shares at $45.25 ($175,615)
- 4 Open-market sale EVP and Chief Legal Officer sold 3,161 shares at $45.25 ($143,035)
- 4 Open-market sale CBO & EVP sold 1,968 shares at $45.27 ($89,091)
- 4 Open-market sale SVP, Chief Accounting Officer sold 100 shares at $45.65 ($4,565)
- 4 Open-market sale Huang Dennis Karl sold 389 shares at $45.65 ($17,758)
- 4 Open-market sale Pinion John Richard sold 3,755 shares at $45.26 ($169,951)
- 4 Shares withheld for taxes President & CEO gave up 16,140 shares (to pay taxes)
- 4 Open-market sale EVP & Chief Commercial Officer sold 3,664 shares at $45.25 ($165,796)
- 4 Open-market sale SVP, Chief Accounting Officer sold 639 shares at $43.40 ($27,733)
- 4 Open-market sale President & CEO sold 19,582 shares at $45.57 ($892,352)
- 4 Open-market sale SVP, Chief Accounting Officer sold 2,031 shares at $43.96 ($89,283)
- 4 Open-market sale CFO & Executive Vice President sold 1,629 shares at $40.16 ($65,421)
- 4 Open-market sale CFO & Executive Vice President sold 3,484 shares at $38.22 ($133,158)
- 4 Grant or award CFO & Executive Vice President acquired 20,000 shares (grant or award)
- 4 Grant or award SVP, Chief Accounting Officer acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
- 4 Grant or award Director acquired 3,300 shares (grant or award)
Page 7 of 32 · 627 filings